PAVmed Stock (NASDAQ: PAVM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 65.16K |
Day Range | - - - |
52 Wk Range | 0.60 - 9.00 |
Market Cap | $8.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 3.16% |
Days to Cover | 4.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PAVmed (NASDAQ:PAVM) through any online brokerage.
Other companies in PAVmed’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
There is no analysis for PAVmed.
PAVmed has a consensus price target of $1.45.
The stock price for PAVmed (NASDAQ: PAVM) is $0.945 last updated July 18, 2024 at 6:39 PM EDT.
There are no upcoming dividends for PAVmed.
PAVmed’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for PAVmed.
PAVmed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.